EOM Pharmaceuticals Holdings, Inc. (IMUC)
OTCMKTS · Delayed Price · Currency is USD
0.1100
-0.0031 (-2.74%)
Oct 28, 2025, 9:30 AM EDT
IMUC Statistics
Total Valuation
IMUC has a market cap or net worth of 22.77 million.
| Market Cap | 22.77M |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
IMUC has 126.50 million shares outstanding.
| Current Share Class | 126.50M |
| Shares Outstanding | 126.50M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -6.11 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.97
| Current Ratio | 0.97 |
| Quick Ratio | 0.75 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.10 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -440.45% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 12,683.59% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.28M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -21.43% in the last 52 weeks. The beta is 0.60, so IMUC's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | -21.43% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.11 |
| Relative Strength Index (RSI) | 65.24 |
| Average Volume (20 Days) | 23,341 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.00 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.57M |
| Pretax Income | -5.13M |
| Net Income | -5.13M |
| EBITDA | n/a |
| EBIT | -2.57M |
| Earnings Per Share (EPS) | -0.05 |
Balance Sheet
The company has 551,176 in cash and 3.05 million in debt, giving a net cash position of -2.50 million or -0.02 per share.
| Cash & Cash Equivalents | 551,176 |
| Total Debt | 3.05M |
| Net Cash | -2.50M |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | -3.73M |
| Book Value Per Share | -0.03 |
| Working Capital | -20,254 |
Cash Flow
| Operating Cash Flow | -2.79M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IMUC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -118.93% |
| Shareholder Yield | -118.93% |
| Earnings Yield | -22.52% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |